BIPSS should be recommended in patients with ACTH-dependent CS whose clinical, biochemical, or radiological studies are discordant or equivocal, according to the consensus on the management of Cushing’s syndrome (16). The gene discussed is POMC; the disease is Cushing syndrome due to macronodular adrenal hyperplasia.